Lysomal Acid Lipase Deficiency or LAL, A Rare Disease

Synageva believes every second counts when developing life-changing orphan treatments. Our current lead program focuses on enzyme replacement therapy for Lysomal Acid Lipase Deficiency or LAL. Tune-in to Lifetime Television’s The Balancing Act as this popular cable television show is joined by noted metabolic geneticist and physician, Doctor Olaf Bodamer from The University of Miami. This lively, informative segment explores and examines what’s being done for this debilitating disease – a condition which affects the liver and attack all age groups including newborn infants. This close-up and personal features two women – a mother whose daughter fought the disease and lost her battle, and a young woman currently battling LAL.